Hong Kong's Market Slips Amid Surprising HSBC Loss

Hong Kong's stock market declined due to HSBC's unexpected $400 million loss linked to a UK fraud case. Despite the downturn, a new IPO boom emerged with Star Sports Medicine debuting 120% higher. Meanwhile, CATL's shares led gains with their sodium-ion battery deal, amid subdued trading due to regional holidays.

On Tuesday, Hong Kong's stock market saw a decline following an unexpected financial setback at HSBC. The banking giant reported a $400 million loan loss tied to a fraud case in the UK, leading to a 5.2% fall in its shares. The benchmark Hang Seng Index closed 0.76% lower at 25,889.61.

Despite the downturn, new IPOs showcased potential, with Star Sports Medicine's stock making an impressive debut, climbing nearly 120% above its offering price. The China-based medical device company raised HK$827.4 million ($105.62 million), reflecting strong market demand.

Elsewhere in the market, battery maker Contemporary Amperex Technology led gains with a 3.7% rise, following news of a novel sodium-ion battery deal. However, broader trading volumes remained light due to holidays in Japan and South Korea, while the offshore yuan held steady amidst regional currency struggles.